218594-35-5

Upstream product

• 2591-86-8 N-Formylpiperidine 
• 218594-34-4 (4-bromo-2-methylphenyl)methoxy-tert-butyldiphenylsilane 
• 68-12-2 N,N-dimethyl-formamide 
• 17100-58-2 4-bromo-2-methylbenzyl alcohol 
• 58479-61-1 tert-butylchlorodiphenylsilane 

Downstream Products

• 1292291-38-3 Ethyl (3S)-3-[4-[[4-[(tert-butyl(diphenyl)silyl)oxymethyl]-3-methyl-phenyl]methoxy]phenyl]hex-4-ynoate 
• 1292291-36-1 [4-[(tert-butyl(diphenyl)silyl)oxymethyl]-3-methyl-phenyl]methanol 
• 1292291-37-2 [4-(bromomethyl)-2-methyl-phenyl]methoxy-tert-butyl-diphenyl-silane 

Relevant academic research and scientific papers

SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

Provided herein are 4-aminoisoindoline-1,3-dione compounds having the following structure: wherein R, Ring A, and n are as defined herein, compositions comprising an effective amount of a 4-aminoisoindoline-1,3-dione compound, and methods for treating or preventing disorders.

Novel Spiropiperidine Compounds

A compound of the formula: or a pharmaceutically acceptable salt thereof as well as a pharmaceutical composition, and a method for treating diabetes.

AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS

This invention relates to piperazine derivatives of formula (I), wherein Y is bond or lower alkylene, R1 is aryl which may have substituent(s), R2 is aryl or indolyl, each of which may have substituent(s), R3 is hydrogen or lower alkyl, and R4 is as defined in the description, and its pharmaceutically acceptable salt, to processes for preparation thereof, to pharmaceutical composition comprising the same, and to a use of the same for treating or preventing Tachykinin-mediated diseases in human beings or animals. 1